1. Home
  2. RRX vs VTRS Comparison

RRX vs VTRS Comparison

Compare RRX & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RRX
  • VTRS
  • Stock Information
  • Founded
  • RRX 1955
  • VTRS 1961
  • Country
  • RRX United States
  • VTRS United States
  • Employees
  • RRX N/A
  • VTRS N/A
  • Industry
  • RRX
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • RRX
  • VTRS Health Care
  • Exchange
  • RRX Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • RRX 9.6B
  • VTRS 11.1B
  • IPO Year
  • RRX 1987
  • VTRS N/A
  • Fundamental
  • Price
  • RRX $145.07
  • VTRS $10.36
  • Analyst Decision
  • RRX Strong Buy
  • VTRS Hold
  • Analyst Count
  • RRX 10
  • VTRS 6
  • Target Price
  • RRX $174.80
  • VTRS $11.17
  • AVG Volume (30 Days)
  • RRX 757.8K
  • VTRS 7.0M
  • Earning Date
  • RRX 10-29-2025
  • VTRS 11-06-2025
  • Dividend Yield
  • RRX 0.97%
  • VTRS 4.63%
  • EPS Growth
  • RRX 22.50
  • VTRS N/A
  • EPS
  • RRX 3.87
  • VTRS N/A
  • Revenue
  • RRX $5,872,300,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • RRX N/A
  • VTRS N/A
  • Revenue Next Year
  • RRX $3.83
  • VTRS $1.61
  • P/E Ratio
  • RRX $37.49
  • VTRS N/A
  • Revenue Growth
  • RRX N/A
  • VTRS N/A
  • 52 Week Low
  • RRX $90.56
  • VTRS $6.85
  • 52 Week High
  • RRX $185.28
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • RRX 50.12
  • VTRS 59.26
  • Support Level
  • RRX $143.60
  • VTRS $10.22
  • Resistance Level
  • RRX $153.68
  • VTRS $10.46
  • Average True Range (ATR)
  • RRX 5.48
  • VTRS 0.20
  • MACD
  • RRX 0.40
  • VTRS 0.02
  • Stochastic Oscillator
  • RRX 55.07
  • VTRS 80.00

About RRX Regal Rexnord Corporation

Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: